MAPT and Cognitive impairment: Because the progression of amyloid-beta and tau pathology is strongly correlated with the degree of cognitive impairment (Wu et al., 2020), moderate to severe TBI is correlated with a two- to fourfold increased risk of developing subsequent cognitive impairment (Walker et al., 2022).